Stay informed with the latest litigation news. Explore now

Regen Lab competitive analysis

Latest publications and patents of Regen Lab New

Explore the latest publications and patents granted to Regen Lab, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Regen Lab

Feb 22, 2023Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In VivoGranted And Under Opposition
Apr 27, 2022Process, Tube And Device For The Preparation Of Wound Healant CompositionGranted And Under Opposition
Aug 19, 2020Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In VivoRevoked

Explore patent oppositions filed by Regen Lab against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Assembly, Device Kit And Method For Preparing Platelet-Rich Plasma (Prp)ESTERONDec 17, 2021
A System And Method For Obtaining A Cellular Sample Enriched With Defined Cells Such As Platelet Rich Plasma(Prp)ESTARDec 10, 2021

Explore Regen Lab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 22, 2023Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In Vivo1
Apr 27, 2022Process, Tube And Device For The Preparation Of Wound Healant Composition1
Aug 19, 2020Cell Preparations For Extemporaneous Use, Useful For Healing And Rejuvenation In Vivo1

Latest PTAB cases involving Regen Lab New

Discover the latest PTAB cases involving Regen Lab, highlighting their recent legal challenges and patent disputes.

Top competitors of Regen Lab

Top competitors of Regen Lab based on patent oppositions.